The transcription factor FOXM1 is upregulated and overexpressed in aggressive, therapy-resistant forms of hormone receptor-positive and triple negative breast cancers, and is associated with less good patient survival. This evidence concerns the gene FOXM1 and triple-negative breast carcinoma.